Walleye Trading
CPRX

Walleye Trading’s Catalyst Pharmaceutical CPRX Stock Holding History

Walleye Trading’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,489
Closed -$9K – 4725
2018
Q3 		$9K Buy
+2,489
New +$7.8K ﹤0.01% 5004
2017
Q1 		– Sell
-1,900
Closed -$2K – 4731
2016
Q4 		$2K Sell
1,900
-300
-14% -$343 ﹤0.01% 4555
2016
Q3 		$2K Hold
2,200
– – ﹤0.01% 4661
2016
Q2 		$2K Sell
2,200
-400
-15% -$322 ﹤0.01% 5106
2016
Q1 		$3K Buy
+2,600
New +$4.03K ﹤0.01% 5045
2015
Q3 		– Sell
-1,400
Closed -$6K – 5025
2015
Q2 		$6K Buy
+1,400
New +$5.58K ﹤0.01% 4440

Other funds holding CPRX

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Walleye Trading's CPRX Position: Q4 2018 in Review

Walleye Trading sold out of Catalyst Pharmaceutical (CPRX) in Q4 2018, closing a stake of 2,489 shares — an estimated $9K sold.

Walleye Trading first reported a position in CPRX in Q2 2015 and held it in 6 quarters. The position peaked at $9K in Q3 2018. 86 funds tracked by Wall St. Rank hold CPRX as of Q4 2018.

  • Walleye Trading reported no remaining Catalyst Pharmaceutical position as of Q4 2018 after selling out during the quarter.
  • Walleye Trading sold 2,489 Catalyst Pharmaceutical shares in Q4 2018, an estimated $9K.
  • Walleye Trading first reported a position in Catalyst Pharmaceutical in Q2 2015 and held it in 6 quarters.
  • Walleye Trading's Catalyst Pharmaceutical position peaked at $9K in Q3 2018.
  • 86 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q4 2018.

Based on Walleye Trading's 13F filing for Q4 2018, filed 14 Feb 2019.